The study aimed to assess how well an influenza vaccine works in 37 HIV-infected patients compared to 29 uninfected individuals, focusing on their immune response and monitoring for influenza over 6 months.*
-
Both groups showed antibody increases after vaccination, but uninfected individuals had significantly higher antibody levels for H1N1 and H3N2, with only 67.6% of HIV patients developing protective antibodies for H1N1 compared to 96.6% in the control group.*
-
The most common viruses found in both groups during infection episodes were rhinovirus and, to a lesser extent, coronavirus and adenovirus, with 65% of respiratory infections in the HIV group linked to viral agents